2,4-Dioxo-3-quinazolinylaryl sulfonylureas

Details for Australian Patent Application No. 2004278030 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Scarborough, Robert M.; Zhang, Xiaoming; Bauer, Shawn M.; Huang, Wolin; Pandey, Anjali; Jia, Zhaozhong J.

Agent Pizzeys

Pub. Number AU-B-2004278030

PCT Pub. Number WO2005/032488

Priority 60/508,564 03.10.03 US

Filing date 29 September 2004

Wipo publication date 14 April 2005

Acceptance publication date 1 July 2010

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032488 Priority application(s): WO2005/032488

1 July 2010 Application Accepted

  Published as AU-B-2004278030

2 December 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Jul 2010

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278035-Methods and compositions for Mycoplasma pneumoniae exotoxins

2004278028-Method of coating an SLA part